Darin J. Weber - 08 Jul 2025 Form 4 Insider Report for PROKIDNEY CORP. (PROK)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
09 Jul 2025, 16:28:11 UTC
Prior SEC filing
04 Mar 2025
Next SEC filing
03 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Todd Girolamo, attorney in fact

Key filing fact

Darin J. Weber filed Form 4 for PROKIDNEY CORP. (PROK) on 09 Jul 2025.

Key facts

  • This page summarizes Darin J. Weber's Form 4 filing for PROKIDNEY CORP. (PROK).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 09 Jul 2025, 16:28.

Change

  • Previous filing in this sequence was filed on 04 Mar 2025.
  • Current net transaction value: -$312,510.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001936228 Primary reporting owner

Weber Darin J.

Relationship
Chief Regulatory Officer
Address
C/O PROKIDNEY CORP, 2000 FRONTIS PLAZA BLVD, SUITE 250, WINSTON-SALEM
Signature
/s/ Todd Girolamo, attorney in fact
Signature date
09 Jul 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PROK transaction

Class A Common Stock

Sale

Transaction value
$312,510
Shares
-103,480
Change %
-100%
Price
$3.02
Shares after
0
Date
08 Jul 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 1 footnote

Footnote F1

The reported sale of stock occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 15, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .